LOXL1-AS1 Inhibits JAK2 Ubiquitination and Promotes Cholangiocarcinoma Progression through JAK2/STAT3 Signaling
LOXL1-AS1 Promotes Cholangiocarcinoma Progression by Regulating the JAK2/STAT3 Signaling Pathway Academic Background Cholangiocarcinoma (CCA) is a malignant tumor originating from biliary epithelium, presenting significant medical challenges. Its incidence shows geographical variation, being particularly high in Asia and South America. The occurren...